Shares of Roche Holding Ltd. (NASDAQ:RHHBY) have been given a consensus recommendation of “Hold” by the thirteen ratings firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $38.00.
Several brokerages recently weighed in on RHHBY. UBS AG cut shares of Roche Holding from a “buy” rating to a “neutral” rating in a research report on Thursday, July 6th. Cowen and Company set a $38.00 price target on shares of Roche Holding and gave the stock a “buy” rating in a research report on Monday, July 10th. Morgan Stanley restated an “equal weight” rating on shares of Roche Holding in a research report on Wednesday, July 26th. BNP Paribas cut shares of Roche Holding from a “neutral” rating to an “underperform” rating in a research report on Tuesday, September 26th. Finally, Citigroup Inc. cut shares of Roche Holding from a “buy” rating to a “neutral” rating in a research report on Wednesday, October 18th.
ILLEGAL ACTIVITY WARNING: This piece was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://www.com-unik.info/2017/10/31/roche-holding-ltd-rhhby-receives-consensus-recommendation-of-hold-from-brokerages.html.
Roche Holding (NASDAQ RHHBY) traded up 0.295% during trading on Thursday, reaching $28.915. 1,239,855 shares of the company’s stock were exchanged. The company has a market cap of $197.38 billion and a P/E ratio of 20.502. The stock’s 50-day moving average is $31.16 and its 200-day moving average is $32.05. Roche Holding has a 12-month low of $25.25 and a 12-month high of $36.82.
A number of hedge funds and other institutional investors have recently bought and sold shares of RHHBY. Teachers Retirement System of The State of Kentucky boosted its stake in Roche Holding by 2.2% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 96,840 shares of the company’s stock worth $3,102,000 after buying an additional 2,100 shares during the period. New England Research & Management Inc. boosted its stake in shares of Roche Holding by 40.3% during the second quarter. New England Research & Management Inc. now owns 22,627 shares of the company’s stock valued at $720,000 after purchasing an additional 6,500 shares during the period. Kempner Capital Management Inc. boosted its stake in shares of Roche Holding by 2.2% during the second quarter. Kempner Capital Management Inc. now owns 52,556 shares of the company’s stock valued at $1,675,000 after purchasing an additional 1,116 shares during the period. Edmp Inc. purchased a new stake in shares of Roche Holding during the second quarter valued at $207,000. Finally, Eqis Capital Management Inc. boosted its stake in shares of Roche Holding by 10.0% during the second quarter. Eqis Capital Management Inc. now owns 38,087 shares of the company’s stock valued at $1,211,000 after purchasing an additional 3,450 shares during the period.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
What are top analysts saying about Roche Holding Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Roche Holding Ltd. and related companies.